Prop 65 Compliance for Nail Polish (Toxic Trio + PFAS + AB 2762)

Nail Polish Sits at a Four-Regime Crossroads

Nail polish is regulated simultaneously by Prop 65, AB 2762 (intentional-addition ban), AB 2771 (PFAS reporting), and the DTSC Priority Product regulation. The “Toxic Trio” — DBP, toluene, and formaldehyde — is named across all four regimes.

Why This Matters

• The Toxic Trio: DBP, toluene, and formaldehyde remain central litigation triggers.
• PFAS scrutiny: AB 2771 reporting expands regulatory exposure.
• Salon-air inhalation: Vapor generation affects both workers and consumers.
• “N-Free” claims: Marketing claims must be documented and verifiable.

By the Numbers — Regulatory Thresholds

• 0.5 µg/day — Prop 65 reproductive MADL (where applicable)
• 100 ppm — DTSC toluene Priority Product trigger
• Jan 2025 — AB 2762 intentional-addition ban start date

Four Risk Drivers Converge in Every Bottle

Each SKU carries overlapping formulation and exposure risks.

• Raw materials: Globally sourced solvents, resins, plasticizers.
• Formulation: Entry point for DBP, toluene, formaldehyde, PFAS.
• Application exposure: Vapor inhalation + dermal contact.
• Retail claims: “3-Free” / “10-Free” claims require substantiation.

One bottle. Four regimes. Documentation must satisfy them all.

Chemical Inventory (Category Chemicals of Concern)

• Dibutyl Phthalate (DBP) — reproductive toxicity
• Toluene — developmental toxicity
• Formaldehyde — carcinogen
• PFAS — persistent chemicals (AB 2771)
• Methacrylates — inhalation & dermal sensitizers

Risk Profile by Product Format

• Traditional solvent polish: Toxic Trio exposure high
• Gel polish: methacrylate & PFAS scrutiny med–high
• “N-Free” formulas: documentation burden high
• Salon-only products: Cal/OSHA inhalation risk high

A Five-Pillar Compliance Program

• Pillar 1 — Hazard identification: solvent, plasticizer & PFAS screening
• Pillar 2 — Exposure assessment: inhalation & dermal modeling vs safe harbor
• Pillar 3 — Verification testing: GC‑MS quantification of Toxic Trio + PFAS
• Pillar 4 — Warning determination: compliant Prop 65 labeling logic
• Pillar 5 — Records & reassessment: supplier attestations + DTSC reporting files

Verification Testing — What, How, How Often

• Toxic Trio: GC‑MS — per lot
• PFAS panel: targeted analysis where applicable
• Exposure modeling: vapor-generation + dermal frequency
• Trend review: monthly compliance oversight

ISO/IEC 17025 accredited laboratories only. All batch results tied to documented compliance determinations.

90-Day Implementation Plan (Three Sprints)

Days 1–30 — Discover

• SKU intake & ingredient mapping
• Regulatory crosswalk (Prop 65 + AB 2762 + DTSC)
• Testing plan creation
• Initial gap report

Days 31–60 — Build

• Toxic Trio testing program artifact
• Exposure evaluation framework
• Supplier compliance pack rollout
• Warning label matrix

Days 61–90 — Validate

• Mock NOV tabletop
• Internal audit + corrective actions
• QI approval & document control handoff